Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Neoplasm Metastasis × Therapeutics × Clear all

Phase

Status

Completed 4 Not yet recruiting 2 Unknown 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Prostatic Neoplasms 3 Neoplasms 2 Multiple Myeloma 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Graft vs Host Disease 2 Fatigue 2 Breast Neoplasms 2 Brain Neoplasms 2 Blast Crisis 2 Waldenstrom Macroglobulinemia 1 Stage IA Uterine Sarcoma 1 Spinal Cord Neoplasms 1 Spinal Cord Compression 1 Sezary Syndrome 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Paranasal Sinus Neoplasms 1 Oligodendroglioma 1 Neurologic Manifestations 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1

Interventions

pembrolizumab 21 Capecitabine 21 Bevacizumab 20 Gemcitabine 18 Cyclophosphamide 18 Fluorouracil 17 aldesleukin 15 Leucovorin 15 Docetaxel 15 Paclitaxel 13 Nivolumab 13 Irinotecan 13 Radiosurgery 12 Oxaliplatin 12 Interleukin-2 12 fludarabine 10 Drug Therapy 10 Cisplatin 10 Albumin-Bound Paclitaxel 10 fludarabine phosphate 9 Cetuximab 9 Carboplatin 9 Everolimus 8 Doxorubicin 8 Zoledronic Acid 7 Trastuzumab 7 Sunitinib 7 Radiotherapy 7 Celecoxib 7 130-nm albumin-bound paclitaxel 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05904236 2025-04-08

ICVB-1042

IconOVir Bio

Phase 1 Terminated

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡